Cannabis Sativa (OTC: CBDS)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Cannabis Sativa (OTCQB: CBDS) through any online brokerage.
There are no as such competitors for Cannabis Sativa.
The latest price target for Cannabis Sativa (OTCQB: CBDS) was reported by Credit Suisse on Friday, August 12, 2022. The analyst firm set a price target for 74.00 expecting CBDS to rise to within 12 months (a possible 70309.13% upside). 50 analyst firms have reported ratings in the last year.
The stock price for Cannabis Sativa (OTCQB: CBDS) is $0.1051 last updated August 11, 2022, 7:59 PM UTC.
The next Cannabis Sativa (CBDS) dividend date is projected to be Tuesday, August 23, 2022.
Cannabis Sativa’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Cannabis Sativa.
Cannabis Sativa is in the Health Care sector and Health Care Providers & Services industry. They are listed on the OTCQB.